More about
Refractory Anemia
News
July 07, 2020
2 min read
Save
FDA approves Inqovi as at-home treatment for myelodysplastic syndrome
The FDA approved the oral combination of decitabine and cedazuridine for treatment of adults with myelodysplastic syndrome.